Literature DB >> 21835793

Fitness costs and diversity of the cytotoxic T lymphocyte (CTL) response determine the rate of CTL escape during acute and chronic phases of HIV infection.

Vitaly V Ganusov1, Nilu Goonetilleke, Michael K P Liu, Guido Ferrari, George M Shaw, Andrew J McMichael, Persephone Borrow, Bette T Korber, Alan S Perelson.   

Abstract

HIV-1 often evades cytotoxic T cell (CTL) responses by generating variants that are not recognized by CTLs. We used single-genome amplification and sequencing of complete HIV genomes to identify longitudinal changes in the transmitted/founder virus from the establishment of infection to the viral set point at 1 year after the infection. We found that the rate of viral escape from CTL responses in a given patient decreases dramatically from acute infection to the viral set point. Using a novel mathematical model that tracks the dynamics of viral escape at multiple epitopes, we show that a number of factors could potentially contribute to a slower escape in the chronic phase of infection, such as a decreased magnitude of epitope-specific CTL responses, an increased fitness cost of escape mutations, or an increased diversity of the CTL response. In the model, an increase in the number of epitope-specific CTL responses can reduce the rate of viral escape from a given epitope-specific CTL response, particularly if CD8+ T cells compete for killing of infected cells or control virus replication nonlytically. Our mathematical framework of viral escape from multiple CTL responses can be used to predict the breadth and magnitude of HIV-specific CTL responses that need to be induced by vaccination to reduce (or even prevent) viral escape following HIV infection.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21835793      PMCID: PMC3187476          DOI: 10.1128/JVI.00655-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  96 in total

1.  Not all cytokine-producing CD8+ T cells suppress simian immunodeficiency virus replication.

Authors:  Chungwon Chung; Wonhee Lee; John T Loffredo; Benjamin Burwitz; Thomas C Friedrich; Juan Pablo Giraldo Vela; Gnankang Napoe; Eva G Rakasz; Nancy A Wilson; David B Allison; David I Watkins
Journal:  J Virol       Date:  2006-11-29       Impact factor: 5.103

Review 2.  Apoptosis induced by the lymphocyte effector molecule perforin.

Authors:  Paul Bolitho; Ilia Voskoboinik; Joseph A Trapani; Mark J Smyth
Journal:  Curr Opin Immunol       Date:  2007-04-17       Impact factor: 7.486

3.  The antiviral efficacy of simian immunodeficiency virus-specific CD8+ T cells is unrelated to epitope specificity and is abrogated by viral escape.

Authors:  John T Loffredo; Benjamin J Burwitz; Eva G Rakasz; Sean P Spencer; Jason J Stephany; Juan Pablo Giraldo Vela; Sarah R Martin; Jason Reed; Shari M Piaskowski; Jessica Furlott; Kim L Weisgrau; Denise S Rodrigues; Taeko Soma; Gnankang Napoé; Thomas C Friedrich; Nancy A Wilson; Esper G Kallas; David I Watkins
Journal:  J Virol       Date:  2006-12-27       Impact factor: 5.103

4.  Estimation of the rate of killing by cytotoxic T lymphocytes in vivo.

Authors:  Roland R Regoes; Daniel L Barber; Rafi Ahmed; Rustom Antia
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-22       Impact factor: 11.205

5.  In vivo CD8+ T cell control of immunodeficiency virus infection in humans and macaques.

Authors:  Becca Asquith; Angela R McLean
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-02       Impact factor: 11.205

6.  In vivo T lymphocyte dynamics in humans and the impact of human T-lymphotropic virus 1 infection.

Authors:  Becca Asquith; Yan Zhang; Angelina J Mosley; Catherine M de Lara; Diana L Wallace; Andrew Worth; Lambrini Kaftantzi; Kiran Meekings; George E Griffin; Yuetsu Tanaka; David F Tough; Peter C Beverley; Graham P Taylor; Derek C Macallan; Charles R M Bangham
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-01       Impact factor: 11.205

7.  Dynamics of CD8+ T cell responses during acute and chronic lymphocytic choriomeningitis virus infection.

Authors:  Christian L Althaus; Vitaly V Ganusov; Rob J De Boer
Journal:  J Immunol       Date:  2007-09-01       Impact factor: 5.422

8.  Estimating the effectiveness of simian immunodeficiency virus-specific CD8+ T cells from the dynamics of viral immune escape.

Authors:  Judith N Mandl; Roland R Regoes; David A Garber; Mark B Feinberg
Journal:  J Virol       Date:  2007-08-15       Impact factor: 5.103

9.  High throughput functional analysis of HIV-1 env genes without cloning.

Authors:  Jennifer L Kirchherr; Xiaozhi Lu; Webster Kasongo; Victor Chalwe; Lawrence Mwananyanda; Rosemary M Musonda; Shi-Mao Xia; Richard M Scearce; Hua-Xin Liao; David C Montefiori; Barton F Haynes; Feng Gao
Journal:  J Virol Methods       Date:  2007-04-09       Impact factor: 2.014

10.  Effective T-cell responses select human immunodeficiency virus mutants and slow disease progression.

Authors:  A J Frater; H Brown; A Oxenius; H F Günthard; B Hirschel; N Robinson; A J Leslie; R Payne; H Crawford; A Prendergast; C Brander; P Kiepiela; B D Walker; P J R Goulder; A McLean; R E Phillips
Journal:  J Virol       Date:  2007-04-04       Impact factor: 5.103

View more
  82 in total

1.  Selection and accumulation of an HIV-1 escape mutant by three types of HIV-1-specific cytotoxic T lymphocytes recognizing wild-type and/or escape mutant epitopes.

Authors:  Tomohiro Akahoshi; Takayuki Chikata; Yoshiko Tamura; Hiroyuki Gatanaga; Shinichi Oka; Masafumi Takiguchi
Journal:  J Virol       Date:  2011-12-07       Impact factor: 5.103

2.  Impaired immune evasion in HIV through intracellular delays and multiple infection of cells.

Authors:  Christian L Althaus; Rob J De Boer
Journal:  Proc Biol Sci       Date:  2012-04-04       Impact factor: 5.349

Review 3.  Viral quasispecies evolution.

Authors:  Esteban Domingo; Julie Sheldon; Celia Perales
Journal:  Microbiol Mol Biol Rev       Date:  2012-06       Impact factor: 11.056

4.  Expansion of polyfunctional HIV-specific T cells upon stimulation with mRNA electroporated dendritic cells in the presence of immunomodulatory drugs.

Authors:  Brenda De Keersmaecker; Sabine D Allard; Patrick Lacor; Rik Schots; Kris Thielemans; Joeri L Aerts
Journal:  J Virol       Date:  2012-06-20       Impact factor: 5.103

5.  The dynamics of HIV-1 adaptation in early infection.

Authors:  Jack da Silva
Journal:  Genetics       Date:  2011-12-29       Impact factor: 4.562

6.  Antibody escape kinetics of equine infectious anemia virus infection of horses.

Authors:  Elissa J Schwartz; Seema Nanda; Robert H Mealey
Journal:  J Virol       Date:  2015-04-15       Impact factor: 5.103

7.  Genetic analyses of HIV env associated with uveitis in antiretroviral-naive individuals.

Authors:  Corey A Williams-Wietzikoski; Isaac D So; Marta E Bull; Tanawan Samleerat; Kessara Pathanapitoon; Paradee Kunavisarut; Natedao Kongyai; Nicole Ngo-Giang-Huong; Lisa M Frenkel; Wasna Sirirungsi
Journal:  AIDS       Date:  2017-08-24       Impact factor: 4.177

8.  Within-Epitope Interactions Can Bias CTL Escape Estimation in Early HIV Infection.

Authors:  Victor Garcia; Marcus W Feldman
Journal:  Front Immunol       Date:  2017-05-01       Impact factor: 7.561

9.  Vertical T cell immunodominance and epitope entropy determine HIV-1 escape.

Authors:  Michael K P Liu; Natalie Hawkins; Adam J Ritchie; Vitaly V Ganusov; Victoria Whale; Simon Brackenridge; Hui Li; Jeffrey W Pavlicek; Fangping Cai; Melissa Rose-Abrahams; Florette Treurnicht; Peter Hraber; Catherine Riou; Clive Gray; Guido Ferrari; Rachel Tanner; Li-Hua Ping; Jeffrey A Anderson; Ronald Swanstrom; Myron Cohen; Salim S Abdool Karim; Barton Haynes; Persephone Borrow; Alan S Perelson; George M Shaw; Beatrice H Hahn; Carolyn Williamson; Bette T Korber; Feng Gao; Steve Self; Andrew McMichael; Nilu Goonetilleke
Journal:  J Clin Invest       Date:  2012-12-10       Impact factor: 14.808

10.  Design requirements for interfering particles to maintain coadaptive stability with HIV-1.

Authors:  Igor M Rouzine; Leor S Weinberger
Journal:  J Virol       Date:  2012-12-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.